Search for: "Sanofi GmbH"
Results 41 - 60
of 72
Sort by Relevance
|
Sort by Date
7 Oct 2011, 7:16 am
It's Case C-414/11 Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon and it comes all the way from the Polimeles Protodikio Athinon (Greece). [read post]
19 Jun 2011, 9:00 pm
Le recours aurait donc dû être formé au nom de Sanofi-Aventis Deutschland GmbH. [read post]
19 Jun 2011, 3:01 pm
., adversely affected – see A 107) by the decision was Nutrinova (the food ingredients business of Celanese Ventures GmbH, to which company the relevant business assets had been transferred in July 2002). [read post]
15 Mar 2011, 3:52 pm
Judge Susan Illston recently granted summary judgment on a few claims but left others for trial in a massive pharmaceutical patent case between Sanofi-Aventis Deutchland GMBH (Sanofi, plaintiff), Genentech, Inc. [read post]
8 Feb 2011, 7:19 am
" Sanofi-Aventis Deutschland GMBH, et. al. v. [read post]
2 Feb 2011, 3:52 am
Meda Pharma GmbH & Co. [read post]
23 Nov 2010, 2:19 am
GmbH and Sanofi-aventis v. [read post]
2 Nov 2010, 1:40 am
AstraZeneca sought and got a preliminary injunction against Apotex, which was hankering to launch a generic version of the asthma drug Pulmicort. [read post]
15 Oct 2010, 7:49 am
It’s just how Sanofi-aventis, Proctor and Gamble and Citibank stay competitive!! [read post]
15 Sep 2010, 2:15 am
GmbH and Sanofi-aventis v. [read post]
5 May 2010, 4:46 am
(Patent Docs) Plavix (Clopidogrel) – Netherlands: District Court of The Hague finds Sanofi-Aventis’ patent invalid for lack of inventive step in proceedings brought by RatioPharm (EPLAW) Rapamune (Sirolimus) – US: Patent infringement complaint following Paragraph IV certification: Pfizer Inc. et al. v. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
30 Nov 2009, 12:00 am
Stichting de Thuiskopie v Opus Supplies Deutschland GmbH(The 1709 Copyright Blog) ECJ: upholds ‘compulsory licences’ of Green Dot trade mark: Der Grüne Punkt-Duales System Deutschland GmbH v European Commission (JIPLP) ECJ: Manifest inadmissibility of reference for preliminary ruling in Canon Kabushiki Kaisha (C-181/09) (Class 46) (IPKat) Bud court asks ECJ: what is ‘acquiesced’? [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
16 Jun 2009, 7:28 pm
The second case was Sanofi-Aventis [2007] APO 35. [read post]
24 May 2009, 10:58 pm
The opposing party, Sanofi-Aventis Deutschland GmbH, was represented by McDonnell Boehnen Hulbert & Berghoff LLP, of Chicago. [read post]
16 Jan 2009, 7:00 am
(IP Dragon) Patent strategies for foreign R&D work in China (Philip Brooks' Patent Infringement Updates) All clichés but still true: Intellectual Property Rights enforcement in China leaves room for improvement (IP Dragon) Recognition and protection of well-known trade marks (International Law Office) Revised Chinese patent law aims at quality, compulsory licensing (Intellectual Property Watch) Zen and the art of intellectual property in China (IP Dragon) Colombia… [read post]
16 Dec 2008, 11:47 pm
In contrast, in Aventis Pharma Deutschland GmbH v. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
